S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
New CBOE “special perk” helps traders target income every weekend (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt

Syneos Health Stock Price, News & Analysis (NASDAQ:SYNH)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$42.97
$42.99
50-Day Range
$42.48
$42.98
52-Week Range
$22.89
$52.23
Volume
7.39 million shs
Average Volume
1.92 million shs
Market Capitalization
$4.46 billion
P/E Ratio
62.29
Dividend Yield
N/A
Price Target
$39.75

Syneos Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
7.5% Downside
$39.75 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.00
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.46 out of 5 stars

Medical Sector

892nd out of 957 stocks

Diagnostics & Research Industry

4th out of 4 stocks


SYNH stock logo

About Syneos Health Stock (NASDAQ:SYNH)

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.


SYNH Stock News Headlines

Syneos Health Appoints Colin Shannon To Succeed Michelle Keefe As CEO
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
SYNH Syneos Health, Inc.
Syneos Health execs in line for huge payouts with $7B buyout
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Syneos Deadline Alert
See More Headlines
Receive SYNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2021
Today
12/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SYNH
Employees
28,768
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$39.75
High Stock Price Target
$51.00
Low Stock Price Target
$28.00
Potential Upside/Downside
-7.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$266.50 million
Pretax Margin
1.53%

Debt

Sales & Book Value

Annual Sales
$5.39 billion
Cash Flow
$6.72 per share
Book Value
$33.96 per share

Miscellaneous

Free Float
103,366,000
Market Cap
$4.46 billion
Optionable
Optionable
Beta
1.58
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report














SYNH Stock Analysis - Frequently Asked Questions

Should I buy or sell Syneos Health stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 5 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares.
View SYNH analyst ratings
or view top-rated stocks.

What is Syneos Health's stock price target for 2024?

5 brokerages have issued 1 year price objectives for Syneos Health's stock. Their SYNH share price targets range from $28.00 to $51.00. On average, they predict the company's share price to reach $39.75 in the next twelve months. This suggests that the stock has a possible downside of 7.5%.
View analysts price targets for SYNH
or view top-rated stocks among Wall Street analysts.

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) issued its earnings results on Wednesday, November, 3rd. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 8.63% and a net margin of 1.31%. The business's revenue was up 22.7% compared to the same quarter last year. During the same period last year, the business posted $0.93 earnings per share.

What is Alistair Macdonald's approval rating as Syneos Health's CEO?

322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by many different institutional and retail investors. Top institutional investors include Skandinaviska Enskilda Banken AB publ (0.13%), Natixis Advisors L.P. (0.01%), Barclays PLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends
.

This page (NASDAQ:SYNH) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -